Christine Schmid-Tannwald to Treatment Outcome
This is a "connection" page, showing publications Christine Schmid-Tannwald has written about Treatment Outcome.
Connection Strength
0.328
-
Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients. Radiol Oncol. 2024 09 01; 58(3):348-356.
Score: 0.084
-
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors. Radiol Oncol. 2024 06 01; 58(2):196-205.
Score: 0.083
-
Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study. Acta Radiol. 2022 Jul; 63(7):877-888.
Score: 0.069
-
Diffusion-weighted MRI Before and After Robotic Radiosurgery (Cyberknife®) in Primary and Secondary Liver Malignancies: A Pilot Study. Technol Cancer Res Treat. 2015 Apr; 14(2):191-9.
Score: 0.043
-
ECG, clinical and novel CT-imaging predictors of necessary pacemaker implantation after transfemoral aortic valve replacement. Eur J Radiol. 2025 Jan; 182:111835.
Score: 0.022
-
Recurrence after pituitary surgery in adult Cushing's disease: a systematic review on diagnosis and treatment. Endocrine. 2020 11; 70(2):218-231.
Score: 0.016
-
Dynamic 18F-FET PET in newly diagnosed astrocytic low-grade glioma identifies high-risk patients. J Nucl Med. 2014 Feb; 55(2):198-203.
Score: 0.010